TY - JOUR
T1 - Cardiac Positron Emission Tomography
T2 - a Clinical Perspective
AU - Polte, Christian L.
AU - Burck, Iris
AU - Gjertsson, Peter
AU - Lomsky, Milan
AU - Nekolla, Stephan G.
AU - Nagel, Eike
N1 - Publisher Copyright:
© 2016, Springer Science+Business Media New York.
PY - 2016/3/1
Y1 - 2016/3/1
N2 - Cardiac positron emission tomography is a powerful, quantitative, non-invasive imaging modality, which adds valuable diagnostic and prognostic information to the clinical work-up. Myocardial perfusion and viability imaging are, as a result of continuously growing evidence, established clinical indications that may be cost-effective, due to the high diagnostic accuracy of cardiac positron emission tomography, despite high single-test costs. In the field of inflammation imaging, new indications are entering the clinical arena, which may contribute to a better diagnosis and overall patient care, as for instance in patients with cardiac sarcoidosis, prosthetic valve endocarditis and cardiac device infections. This review will discuss the individual strengths and weaknesses of cardiac positron emission tomography and, hence, the resulting clinical usefulness based on the current evidence for an individualized, patient-centered imaging approach.
AB - Cardiac positron emission tomography is a powerful, quantitative, non-invasive imaging modality, which adds valuable diagnostic and prognostic information to the clinical work-up. Myocardial perfusion and viability imaging are, as a result of continuously growing evidence, established clinical indications that may be cost-effective, due to the high diagnostic accuracy of cardiac positron emission tomography, despite high single-test costs. In the field of inflammation imaging, new indications are entering the clinical arena, which may contribute to a better diagnosis and overall patient care, as for instance in patients with cardiac sarcoidosis, prosthetic valve endocarditis and cardiac device infections. This review will discuss the individual strengths and weaknesses of cardiac positron emission tomography and, hence, the resulting clinical usefulness based on the current evidence for an individualized, patient-centered imaging approach.
KW - Cardiovascular inflammation
KW - Myocardial perfusion
KW - Myocardial viability
KW - Patient-centered imaging
KW - Positron emission tomography
UR - http://www.scopus.com/inward/record.url?scp=84957588024&partnerID=8YFLogxK
U2 - 10.1007/s12410-016-9371-3
DO - 10.1007/s12410-016-9371-3
M3 - Review article
AN - SCOPUS:84957588024
SN - 1941-9066
VL - 9
SP - 1
EP - 13
JO - Current Cardiovascular Imaging Reports
JF - Current Cardiovascular Imaging Reports
IS - 3
M1 - 9
ER -